Marcel Lebel

6.4k total citations
88 papers, 2.0k citations indexed

About

Marcel Lebel is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Nephrology. According to data from OpenAlex, Marcel Lebel has authored 88 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Cardiology and Cardiovascular Medicine, 25 papers in Physiology and 22 papers in Nephrology. Recurrent topics in Marcel Lebel's work include Nitric Oxide and Endothelin Effects (21 papers), Blood Pressure and Hypertension Studies (20 papers) and Hormonal Regulation and Hypertension (17 papers). Marcel Lebel is often cited by papers focused on Nitric Oxide and Endothelin Effects (21 papers), Blood Pressure and Hypertension Studies (20 papers) and Hormonal Regulation and Hypertension (17 papers). Marcel Lebel collaborates with scholars based in Canada, United Kingdom and France. Marcel Lebel's co-authors include Richard Larivière, John H. Grose, Mohsen Agharazii, Iris Kingma, Pierre Douville, Simon Desmeules, Fabrice Mac‐Way, Sylvie Robert, Maarten A.D.H. Schalekamp and Sacha A. De Serres and has published in prestigious journals such as The Lancet, The American Journal of Medicine and Hypertension.

In The Last Decade

Marcel Lebel

85 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcel Lebel Canada 26 952 537 446 430 386 88 2.0k
Takahiko Kawagishi Japan 29 1.2k 1.3× 759 1.4× 570 1.3× 819 1.9× 683 1.8× 54 3.3k
Pasquale Fatuzzo Italy 24 913 1.0× 582 1.1× 463 1.0× 237 0.6× 368 1.0× 59 2.3k
Vicente Álvarez Spain 22 1.1k 1.1× 428 0.8× 210 0.5× 179 0.4× 457 1.2× 46 2.2k
Saverio Parlongo Italy 21 1.4k 1.5× 1.0k 1.9× 397 0.9× 268 0.6× 440 1.1× 36 2.8k
Armando Lindner United States 13 530 0.6× 875 1.6× 380 0.9× 270 0.6× 506 1.3× 17 1.9k
Tayfun Eyıleten Türkiye 33 869 0.9× 1.1k 2.1× 380 0.9× 409 1.0× 504 1.3× 71 3.1k
Abdülgaffar Vural Türkiye 33 865 0.9× 1.3k 2.4× 386 0.9× 451 1.0× 563 1.5× 63 3.2k
Mohsen Agharazii Canada 30 952 1.0× 797 1.5× 535 1.2× 259 0.6× 484 1.3× 114 2.5k
Thomas Wiegmann United States 23 1.1k 1.1× 913 1.7× 243 0.5× 642 1.5× 250 0.6× 60 2.2k
Francesco Rapisarda Italy 20 933 1.0× 587 1.1× 279 0.6× 219 0.5× 268 0.7× 45 2.0k

Countries citing papers authored by Marcel Lebel

Since Specialization
Citations

This map shows the geographic impact of Marcel Lebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel Lebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel Lebel more than expected).

Fields of papers citing papers by Marcel Lebel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcel Lebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel Lebel. The network helps show where Marcel Lebel may publish in the future.

Co-authorship network of co-authors of Marcel Lebel

This figure shows the co-authorship network connecting the top 25 collaborators of Marcel Lebel. A scholar is included among the top collaborators of Marcel Lebel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcel Lebel. Marcel Lebel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mac‐Way, Fabrice, Sacha A. De Serres, Karine Marquis, et al.. (2014). The impact of warfarin on the rate of progression of aortic stiffness in hemodialysis patients: a longitudinal study. Nephrology Dialysis Transplantation. 29(11). 2113–2120. 36 indexed citations
2.
Ung, Roth‐Visal, et al.. (2013). Vascular remodeling and media calcification increases arterial stiffness in chronic kidney disease. Clinical and Experimental Hypertension. 36(3). 173–180. 51 indexed citations
3.
Mac‐Way, Fabrice, Sacha A. De Serres, Pierre Douville, et al.. (2011). Impact of dialysate calcium concentration on the progression of aortic stiffness in patients on haemodialysis. Nephrology Dialysis Transplantation. 26(11). 3695–3701. 28 indexed citations
4.
Campbell, Norman R.C., Janusz Kaczorowski, Richard Lewanczuk, et al.. (2010). 2010 Canadian Hypertension Education Program (CHEP) recommendations: The scientific summary – an update of the 2010 theme and the science behind new CHEP recommendations. Canadian Journal of Cardiology. 26(5). 236–240. 31 indexed citations
5.
Prasad, G. V. Ramesh, Marcel Ruzicka, Kevin D. Burns, Sheldon W. Tobe, & Marcel Lebel. (2009). Hypertension in dialysis and kidney transplant patients. Canadian Journal of Cardiology. 25(5). 309–314. 15 indexed citations
6.
Campbell, Norman R.C., Nadia Khan, Michael D. Hill, et al.. (2009). 2009 Canadian Hypertension Education Program recommendations: The scientific summary – an annual update. Canadian Journal of Cardiology. 25(5). 271–277. 34 indexed citations
7.
Robitaille, Geneviève, et al.. (2005). Neutralization of transforming growth factor-β attenuates hypertension and prevents renal injury in uremic rats. Journal of Hypertension. 23(10). 1895–1903. 121 indexed citations
8.
Sackett, Melanie K., et al.. (2005). The Ask-Upmark kidney: a curable cause of hypertension in young patients. Journal of Human Hypertension. 19(4). 315–316. 9 indexed citations
9.
Douville, Pierre, et al.. (2002). Functional tests for primary aldosteronism: Value of captopril suppression. Current Hypertension Reports. 4(3). 245–249. 12 indexed citations
10.
Zarnke, Kelly B., Finlay A. McAlister, N R Campbell, et al.. (2001). The 2000 Canadian recommendations for the management of hypertension: part two--diagnosis and assessment of people with high blood pressure.. PubMed. 17(12). 1249–63. 11 indexed citations
11.
D'Amours, Martin, et al.. (2001). Blood pressure-independent effect of angiotensin AT1 receptor blockade on renal endothelin-1 production in hypertensive uremic rats. Journal of Hypertension. 19(8). 1479–1487. 21 indexed citations
12.
Côté, Isabelle, D Boucher, & Marcel Lebel. (2001). Renovascular hypertension and focal segmental glomerulosclerosis in the contralateral kidney. Journal of Human Hypertension. 15(2). 143–144. 3 indexed citations
13.
Moreau, Claudia, Richard Larivière, Iris Kingma, John H. Grose, & Marcel Lebel. (2000). CHRONIC NITRIC OXIDE INHIBITION AGGRAVATES HYPERTENSION IN ERYTHROPOIETIN-TREATED RENAL FAILURE RATS. Clinical and Experimental Hypertension. 22(7-8). 663–674. 16 indexed citations
14.
D'Amours, Martin, Marcel Lebel, John H. Grose, & Richard Larivière. (1999). Renal and vascular effects of chronic nitric oxide synthase inhibition: involvement of endothelin 1 and angiotensin II. Canadian Journal of Physiology and Pharmacology. 77(1). 8–16. 21 indexed citations
15.
Moreau, Claudia, et al.. (1999). Endothelin ETA receptor blockade prevents the progression of renal failure and hypertension in uraemic rats. Nephrology Dialysis Transplantation. 14(8). 1881–1888. 36 indexed citations
16.
Lebel, Marcel, et al.. (1998). Renal artery aneurysms and hypertension. Journal of Human Hypertension. 12(11). 765–766. 3 indexed citations
17.
Lebel, Marcel, et al.. (1998). Plasma and Blood Vessel Endothelin-1 Concentrations in Hypertensive Uremic Rats Treated with Erythropoietin. Clinical and Experimental Hypertension. 20(8). 939–951. 17 indexed citations
18.
Lebel, Marcel, et al.. (1997). Increased Immunoreactive Endothelin-1 Levels in Blood Vessels and Glomeruli of Rats with Reduced Renal Mass. Kidney & Blood Pressure Research. 20(6). 372–380. 35 indexed citations
19.
Milot, Alain, Raymond Lambert, Marcel Lebel, Jean R. Cusson, & Pierre Larochelle. (1996). Prostaglandins and renal function in hypertensive patients with unilateral renal artery stenosis and patients with essential hypertension. Journal of Hypertension. 14(6). 765–771. 10 indexed citations
20.
Lebel, Marcel, John H. Grose, & Pierre Falardeau. (1989). Modulation of renal hemodynamics by renal eicosanoids during vasopressor infusions in man. Prostaglandins Leukotrienes and Essential Fatty Acids. 35(1). 41–49. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takahiko Kawagishi Breakdown of academic impact, for papers by Pasquale Fatuzzo Breakdown of academic impact, for papers by Vicente Álvarez Breakdown of academic impact, for papers by Saverio Parlongo Breakdown of academic impact, for papers by Armando Lindner Breakdown of academic impact, for papers by Tayfun Eyıleten Breakdown of academic impact, for papers by Abdülgaffar Vural Breakdown of academic impact, for papers by Mohsen Agharazii Breakdown of academic impact, for papers by Thomas Wiegmann Breakdown of academic impact, for papers by Francesco Rapisarda
Rankless by CCL
2026